Cargando…
DNA 6mA Demethylase ALKBH1 Orchestrates Fatty Acid Metabolism and Suppresses Diet-Induced Hepatic Steatosis
BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver-related morbidity and mortality whereas the pathogenic mechanism remains largely elusive. DNA N6-methyladenosine (6mA) modification is a recently identified epigenetic mark indicative of transcription in eukary...
Autores principales: | Luo, Liping, Liu, Ya, Nizigiyimana, Paul, Ye, Mingsheng, Xiao, Ye, Guo, Qi, Su, Tian, Luo, Xianghang, Huang, Yan, Zhou, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579408/ https://www.ncbi.nlm.nih.gov/pubmed/36058506 http://dx.doi.org/10.1016/j.jcmgh.2022.08.011 |
Ejemplares similares
-
Mammalian ALKBH1 serves as an N(6)-mA demethylase of unpairing DNA
por: Zhang, Min, et al.
Publicado: (2020) -
m(6)A demethylase ALKBH5 suppression contributes to esophageal squamous cell carcinoma progression
por: Xiao, Dong, et al.
Publicado: (2021) -
Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification
por: Hu, Yiyang, et al.
Publicado: (2022) -
RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
por: Qu, Jianwei, et al.
Publicado: (2022) -
N6‐methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation
por: Zhang, Zhen, et al.
Publicado: (2022)